The National Research and Innovation Agency (BRIN) ensures that the assets owned by the Eijkman Institute for Molecular ...
Professor of Microbiology at the Faculty of Medicine at the University of Indonesia (FKUI) Prof. Amin Soebandrio stated ...
The Indonesian Food and Drug Supervisory Agency (BPOM) Head Penny Lukito confirmed that President Joko Widodo (Jokowi) ...
The National Research and Innovation Agency (BRIN) confirmed that the pre-clinical trials of the BRIN Merah Putih ...
State-owned pharmaceutical company PT Bio Farma (Persero) did not conduct an efficacy study of the Red and White ...
State-owned pharmaceutical company PT Bio Farma (Persero) is exploring the possibility of exporting its Merah Putih ...
The Ministry of Health has projected that on a yearly basis, some 2,500 babies in Indonesia are born with thalassemia ...
The Eijkman Institute for Molecular Biology (PRBME) is following up on and supporting the development and preparation ...
The COVID-19 pandemic has wreaked havoc globally, including in Indonesia. It has claimed many lives, increased the ...
Research to develop the Merah Putih (Red and White) vaccine for COVID-19 is a milestone in Indonesia's research and ...
The participants of the Merah Putih (Red and White) vaccine’s clinical trial will be observed for one year, lead ...
The first phase clinical trial of the domestically-produced Merah Putih vaccine is a huge leap for independent vaccine ...
A recent announcement that the Red and White vaccine is expected to be ready for production by mid-2022 offers hope to ...
The National Research and Innovation Agency (BRIN) has signed a licensing cooperation agreement with a private ...
Development of the Red and White vaccine to handle COVID-19 remains a priority in the National Research and Innovation ...